Diagnostic Accuracy of Electrical Impedance Spectroscopy in Non-melanoma Skin Cancer.


Journal

Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310

Informations de publication

Date de publication:
23 Nov 2020
Historique:
pubmed: 11 11 2020
medline: 24 6 2021
entrez: 10 11 2020
Statut: epublish

Résumé

Electrical impedance spectroscopy is a non-invasive technique that can help clinicians in diagnosing malignant skin tumours. Depending on the cellular irregularity of the lesion, electrical impedance spectroscopy can reveal changes in the structure and form of the cells, using a harmless electrical current applied to the skin. A score between 0 and 10 is generated by the electrical impedance spectrometer, where 0 is considered benign and 10 is malignant. This prospective study was conducted in 101 patients with a total of 200 skin lesions; 62 benign and 138 malignant. There was a significant difference between the electrical impedance of malignant and benign lesions (p < 0.001). The sensitivity, specificity, positive predictive value and negative predictive value of electrical impedance spectroscopy for non-melanoma skin cancer were 94.2%, 41.9%, 78.3% and 76.5%, respectively, when the cut-off for the electrical impedance spectroscopy score was set at between 5 and 6. The area under the curve in receiver operating characteristics analyses was 0.758.

Identifiants

pubmed: 33170302
doi: 10.2340/00015555-3689
pmc: PMC9309870
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

adv00328

Références

Contact Dermatitis. 1992 Jul;27(1):37-42
pubmed: 1424589
Clin Dermatol. 2018 May - Jun;36(3):430-432
pubmed: 29908585
J Am Acad Dermatol. 2019 Jan;80(1):285-287
pubmed: 30227189
J Am Acad Dermatol. 2015 Jun;72(6):929-41; quiz 941-2
pubmed: 25980998
Skin Res Technol. 2013 May;19(2):75-83
pubmed: 23350668
J Invest Dermatol. 2017 Sep;137(9):1860-1867
pubmed: 28487088
Exp Dermatol. 2011 Aug;20(8):648-52
pubmed: 21539620
Dermatol Clin. 2017 Oct;35(4):489-493
pubmed: 28886804
Cochrane Database Syst Rev. 2018 Dec 04;12:CD013189
pubmed: 30521690
Skin Res Technol. 2017 Aug;23(3):261-271
pubmed: 27878858
Skin Res Technol. 2005 Nov;11(4):281-6
pubmed: 16221145
Br J Dermatol. 2003 Nov;149 Suppl 66:34-6
pubmed: 14616346
Br J Dermatol. 1996 Feb;134(2):221-8
pubmed: 8746333
Arch Dermatol. 2010 Mar;146(3):288-93
pubmed: 20231500
J Dtsch Dermatol Ges. 2017 Oct;15(10):999-1016
pubmed: 28976087
Br J Dermatol. 2017 Nov;177(5):1432-1438
pubmed: 28421597
Cochrane Database Syst Rev. 2018 Dec 04;12:CD013186
pubmed: 30521691
Br J Dermatol. 2014 Nov;171(5):1099-107
pubmed: 24841846
J Am Acad Dermatol. 2004 Dec;51(6):923-30
pubmed: 15583584
Melanoma Manag. 2016 Jun;3(2):93-96
pubmed: 30190877
Curr Opin Oncol. 2020 Mar;32(2):98-105
pubmed: 31850969
J Eur Acad Dermatol Venereol. 2017 Mar;31 Suppl 2:5-7
pubmed: 28263020

Auteurs

Esra Sarac (E)

Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Liebermeisterstraße 25, DE-72076 Tuebingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH